Metabolite may hold key to new severe asthma therapies
Australian-led research shows patients with severe disease have lower levels of carnitine in their urine, says Dr Stacey Reinke from Edith Cowan University in Perth and fellow author
A key biochemical difference in people with severe asthma has been identified by an Australian-led research project which may lead to better treatment.
The team report the metabolite carnitine decreases in those with severe disease, independently of oral corticosteroid treatment.
